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Abstract 
 
Background 
HIV  infection  is  associated  with  a  wide  range  of 
haematological abnormalities.  
Methods and Objectives   
The objectives in this study were to study haematological 
changes in HIV patients and to correlate them with CD4 cell 
counts. Two hundred and fifty HIV positive patients referred 
to  the  haematology  laboratory  section  for  complete 
haemogram in whom CD4 count was done were included in 
the study. Haematologic parameters and CD4 counts were 
studied in each of these patients.  
Descriptive statistics were applied. Association between two 
attributes was calculated by chi-square test and p value less 
than 0.05 was considered statistically significant. 
Results 
Among 250 patients, anaemia was seen in 210 (84%) cases. 
The  most  common  type  was  normocytic  normochromic 
(40.4%). Lymphopenia was seen in 163 (65.2%) cases and 
thrombocytopenia in 45 (18%) cases. The majority of cases 
(70%) had CD4 cell counts below 200 cells/mm
3. Fifty-four 
cases  (21.6%)  had  CD4  counts  between  200  to  499 
cells/mm
3 and 21 (8.4%) cases had CD4 counts more than 
500 cells/ mm
3. 
In  patients  with  CD4  counts  less  than  200  cells/mm
3, 
anaemia  was  seen  in  91.4%  cases,  leucopenia  in  26.8% 
cases, lymphopenia in 80% cases and thrombocytopenia in 
21.7% cases.  
Conclusion 
Haematologic manifestations of HIV infection are common 
and more frequent with progression of disease. The present 
study revealed a significant increase in the number of cases 
of  anaemia,  and  lymphopenia,  with  decreasing  CD4  cell 
counts. Thrombocytopenia is also seen but does not show 
significant increase with disease progression. The study also 
highlights  the  importance  of  simultaneously  treating  HIV 
patients  for  haematologic  manifestations  to  reduce 
morbidity. 
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What this study adds: 
1. This study highlights the various haematological changes 
occurring in HIV infection which can itself be the cause of 
morbidity. 
2. Total lymphocyte count can be used as predictor of CD4 
cell count in developing countries where CD4 cell estimation 
may not be possible. 
3.  Along  with  HIV  infection  and  secondary  infection 
haematological problems should also be treated. 
 
Background 
Acquired  immunodeficiency  syndrome  (AIDS)  was  first 
recognised  in  1981  and  human  immunodeficiency  virus 
(HIV) was identified in 1983.
1 Globally the phenomenon of 
HIV/AIDS is best viewed as a pandemic affecting nearly all 
the  countries  of  the  world.
2  In  India  there  were  an 
estimated 22.7 lakh individuals living with HIV/AIDS by the 
end of 2008 with an adult prevalence of 0.29%.
3  
Disorders of the haematopoietic system including anaemia, 
leucopenia and thrombocytopenia are common throughout 
the course of HIV infection. These could be due to direct 
effects of HIV infection, secondary infections, neoplasms or 
side  effects  of  therapy.
1  There  are  few  studies  on 
haematological changes in HIV and very few have correlated 
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results with CD4 count. In the present study haematologic 
changes  have  been  correlated  with  CD4  cell  counts  to 
highlight these manifestations with disease progression.  
Method 
The present study was performed between November 2004 
and  May  2006  in  the  department  of  pathology.  HIV 
seropositive  patients  were  referred  from  various 
departments  to  the  haematology  section  for  complete 
haemogram,  those  in  whom  CD4  count  was  done  were 
included  in  the  study.  Patients  on  antiretroviral  therapy 
(ART) and those in whom a complete haemogram was not 
done were excluded from the study. Ethical clearance from 
the institutional ethical committee was obtained. 
 
Haematology  parameters  were  analysed  in  haematology 
auto  analyser  Sysmex  KX-21  which  analyses  using  three 
detector blocks. White blood cell (WBC) count, red blood 
cell  (RBC)  count  and  platelets  are  measured  using  direct 
current detection method. The blood sample fed into the 
analyser  enters  the  transducer  chamber  having  minute 
aperture  on  both  sides  of  which  are  electrodes  between 
which  flows  direct  current.  As  blood  cells  pass  through 
aperture there is change in electrical resistance and blood 
cell size is detected as electric pulses. Blood cell count is 
calculated by counting the pulses and a histogram is plotted 
which  is  analysed  to  obtain  various  analysis  data. 
Differential leucocyte count was done on peripheral smear 
stained  with  leishmann  stain.  Erythrocyte  sedimentation 
rate  (ESR)  was  done  by  Westergren  method.  CD4 
lymphocyte  count  was  done  in  BD  FACS  Calibur 
flowcytometer,  an  automated  multicolour  system  that 
performs both analysis and sorting using dual lasers 488nm 
air cooled argon-ion laser and 635nm red diode laser. Cells 
are treated with monoclonal antibodies CD3, CD4 and CD45 
conjugated  to  different  fluorochromes.  As  a  cell  passes 
through the flow chamber, it is intersected by a laser beam. 
Forward light scatter is proportional to the cell size and right 
angle  scatter  is  related  to  cell  granularity  which  allows 
separation of WBCs based on size and granularity. Analysis 
of fluorescent signals helps in delineating subpopulations. 
Data was analysed by cell quest software. 
Statistical  tests  used  included  mean,  standard  deviation, 
ANOVA (analysis of variance), chi-square test (χ2). The data 
was entered in a Microsoft Office 98 Excel worksheet and 
statistical  analysis  was  done  using  SPSS  version  12. 
Descriptive statistics were applied; p value less than 0.05 
was considered statistically significant. 
 
 
Results 
During the study period 482 HIV patients were referred to 
the  haematology  laboratory.  One  hundred  and  sixty  two 
patients were on ART and in 70 patients the request from 
the clinician was only for haemoglobin and blood counts. 
These patients were excluded from the study. Two hundred 
and fifty patients were included in the study, the age ranged 
from 4 years to 65 years. Mean age was 34.55 ± 9.63 years. 
Nine (3.6%) patients were children less than 12 years. The 
majority of 108 (43.2%) cases were in the age group of 30–
39 years followed by 70 (28%) in 40–49 years, 48 (19.2%) in 
20–29 years, nine (3.6%) in 50–59 years, eight (3.2%) in 0–9 
years, four (1.6%) in 10–19 years and three (1.2%) patients 
were 60 and above years. 
There were 170 (68%) males and 80 (32%) females. Patients 
presented  with  various  clinical  symptoms  like  generalised 
weakness, fever, cough, loose motion, loss of appetite, skin 
lesions, oral lesions, breathlessness, herpes zoster, genital 
lesions and vision problems. None of the patients presented 
with  bleeding.  In  the  present  study  haemoglobin  ranged 
from 2.3 g/dl to 19.3 g/dl. One hundred and twenty (48%) 
patients had haemoglobin less than 10 g/dl, 78 (31.2%) had 
haemoglobin between 10.1-12g/dl and 52 (20.8%) cases had 
haemoglobin  more  than  12g/dl.  RBC  count  ranged  from 
1.02  million/mm
3  to  6.78  million/mm
3.  The  majority  of  
cases 207 (82.8%) had RBC count less than 4.5 million/mm
3. 
Mean corpuscular volume (MCV) ranged from 61.1 to 134.6 
fl, mean corpuscular haemoglobin (MCH) from 16.5 to 44.2 
picograms  and  mean  corpuscular  haemoglobin 
concentration (MCHC) from 25.9 to 36.2 g/dl. MCV in the 
range of 80–99 fl was seen in 178 (71.2%) cases and MCH 
between  27–32  pg  in  122  (48.8%)  cases  indicating 
normocytic  and  normochromic  nature  of  RBCs  in  the 
majority of patients.        
Haematocrit  showed  wide  range  of  7%  to  57.9%.  A 
maximum of 117 (46.8%) cases had a haematocrit between 
31–40%. Red cell distribution width-coefficient of variation 
(RDW-CV)  range  was  12%  to  27%.  164(65.6%)  cases  had 
RDW between 14.1 to 24%.     
Total  leucocyte  count  ranged  from  1400  to  19100 
cells/mm
3. One hundred and seventy six  (70.4%) patients 
had  normal  total  leucocyte  count,  i.e.  between  4000  to 
10000 cells/mm
3. Leucopenia was seen in 52 (20.8%) cases. 
Leucocytosis (more than 10000 cells/mm
3) was seen in 22 
(8.8%) cases. Absolute lymphocyte count ranged from zero 
in one case to 6000 cells/mm
3. One hundred and sixty three 
(65.2%)  cases  had  absolute  lymphocyte  count  less  than 
1500  cells/mm
3  (lymphopenia).  Normal  absolute  Australasian Medical Journal [AMJ 2012, 5, 3, 157-162] 
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lymphocyte  count  (1500-4000  cell/mm
3)  was  seen  in  81 
(32.4%) cases. More than 4000 cells/mm
3 was seen in only 
six (2.4%) cases. 
Platelet count ranged from 18,000/mm
3 to 6,70,000/mm
3. 
Normal platelet count between 1,50,000–400,000 was seen 
in 195 (78%) cases. Platelet count less than 1,50,000/mm
3 
was seen in 45 (18%) cases and more than 400,000/mm
3 
was seen in 10 (4%) cases. 
Anaemia was seen in 210 (84%) cases. The most common 
pattern of anaemia was normocytic normochromic in 101 
(40.4%) cases followed by dimorphic anaemia in 47 (18.8%) 
cases,  normocytic  hypochromic  anaemia  in  29  (11.6%) 
cases, microcytic hypochromic anaemia in 18 (7.2%) cases 
and macrocytic anemia in 15 (6%) cases. Pancytopenia was 
seen  in  17  cases.  Erythrocyte  sedimentation  rate  in  the 
present study ranged from 5 to 155 mm at the end of first 
hour. ESR more than 11 mm was seen in 241(96.4%) cases. 
Mean ESR was 61.2 mm at the end of first hour.  
CD4 lymphocyte count ranged from zero to 1274 cells/mm
3. 
CD4 lymphocyte count less than 200 cells/mm
3 was seen in 
175 (70%) cases, between 200–499 cells/mm
3 was seen in 
54 (21.6%) cases and more than 500 cells/mm
3 was seen in 
21 (8.4%) cases. Haematological parameters in HIV patients 
with different CD4 counts were studied and compared. In 
patients with CD4 counts less than 200 cells/mm
3, 91.4% 
had  anaemia,  26.8%  had  leucopenia  and  21.7%  had 
thrombocytopenia. Observations made in HIV patients with 
different CD4 counts are shown in Table 1.  
Discussion 
Haematological  abnormalities  frequently  encountered  in 
HIV-infected individuals are anaemia, granulocyte disorders, 
thrombocytopenia,  lymphomas,  coagulopathies  and 
vascular malignancies like Kaposi sarcoma. Although in the 
majority of cases, haematologic abnormalities are detected 
in  middle  or  advanced  stages  of  HIV  infection,  some  of 
these  like  anaemia  and  thrombocytopenia  have  been 
reported to occur in early stages of HIV infection.
4 
The  origin  of  haematological  disorders  in  HIV  infection 
remain incompletely understood, but has been attributed to 
dysfunctional  haematopoiesis  in  bone  marrow  caused  by 
several  factors.  These  include  severe  nutritional  stress  in 
advanced stages of HIV infection, suppression of marrow by 
invading  opportunistic  infections  or  neoplasm,  chronic 
disease  associated  changes  and  toxic  side  effects  of 
antiretroviral  compounds  (or  other  medications  used  to 
combat the complications of HIV disease). The possibility of 
HIV  directly  infecting  the  haematopoietic  precursor  cells 
and  inhibiting  their  differentiation  and  development  to 
mature blood cells, has been an attractive hypothesis for 
the origin of HIV associated dysfunctional haematopoiesis, 
but to date it remains, to a great extent, an incompletely 
understood phenomenon.
4 
Table 1: Comparison of haematological parameters in 
patients with different CD4 counts. 
 
Parameter  CD4-
>500 
cells/ 
mm
3 
(n=21) 
CD4-200 
to 499 
cells/ 
mm
3 
(n=54) 
CD4-
<200 
cells/ 
mm
3 
(n=175) 
Statist
-ical  
test 
Remarks  
(p value) 
Anaemia 
(No of 
cases) 
14 
(66.6%) 
36 
(66.7%) 
160 
(91.4%) 

2= 
23.95 
P 
<0.0001 
Total 
leucocyte 
count 
(mean±SD) 
8360 
±3293.9 
6773.7 
±3052.2 
5246.5 
±2248.1 
F= 
18.80 
P 
<0.0001 
Leucopenia  
(No of 
cases) 
1 
(4.8%) 
4 
(7.4%) 
47 
(26.8 %) 

2= 
13.05 
P 
<0.0001 
Abs. 
lymphocyt
e count 
(mean±SD) 
2766 
±1260.6 
1744 
±687.6 
1051 
±554.2 
F= 
74.05 
P 
<0.0001 
Lympho- 
penia 
(No of 
cases) 
2 
(9.5%) 
21 
(38.9%) 
140 
(80%) 

2= 
62.06 
P 
<0.0001 
Platelet 
count 
(mean±SD) 
2.8 
±1.04 
2.3 
±1.09 
2.17 
±1.07 
F= 
3.310 
P 
>0.05 
Thrombocy
topenia 
(No of 
cases) 
1 
(4.8%) 
6 
(11.1%) 
38 
(21.7%) 

2= 
5.86 
P 
>0.05 
ESR 
(mean±SD) 
44.2 
±31.03 
53.75 
±33.61 
65.5 
±32.1 
F= 
5.88 
P 
<0.001 

2 =chi square test, F= analysis of variance (ANOVA) test. 
The present study aims at recognising the haematological 
features of HIV infection which is very important with the 
continuing  rise  in  the  prevalence  of  HIV  infection  in  a 
developing  country  like  India.  In  the  present  study  age 
ranged from 4 years to 65 years and  the majority of the 
patients (156 (62.4%)) were in the age group of 20 to 40 
years. There was male predominance, with a male to female 
ratio of 2.12:1. 
In the present study haemoglobin ranged from 2.3g/dl to 
19.3g/dl with the mean being 10.2. Kaloutsi et al reported 
haemoglobin in the range of 3.8 to 17.3g/dl and a mean of  Australasian Medical Journal [AMJ 2012, 5, 3, 157-162] 
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10.8.
5  However  Treacy  et  al  reported  a  higher  mean 
compared  to  the  present  study  of  11.34.
6  The  majority 
(79.2%)  of  the  cases  in  our  study  had  anaemia  with 
haemoglobin below 12 g/dl. 
Table  2:  Comparison  of  number  of  anaemia  cases  in 
present study with others 
Authors  No of 
anaemia 
cases 
Total 
cases 
Percentage 
Karcher et al  175  197  89 % 
Tripathi et al  61  74  82.4 % 
Sitalakshmi et al  27  42  64.2 % 
Kaloutsi et al  34  40  85 % 
Present study  210  250  84 % 
Table 3: Comparison of morphological patterns of blood 
picture in present study with other studies 
Patterns  of 
blood picture 
Tripathi et al  Khandekar  
et al 
Present 
study 
No.  %  No.  %  No.   % 
Normocytic 
normochromic 
blood picture 
13  17.6 
% 
-  -  40  16 % 
Normocytic 
normochromic 
anaemia 
54  72.9 
% 
68  48.57 
% 
101  40.4 
% 
Normocytic 
hypochromic 
anaemia 
-  -  -  -  29  11.6 
% 
Microcytic 
hypochromic 
anaemia 
4  5.4 %  15  10.71 
% 
18  7.2 
% 
Macrocytic 
anaemia 
3  4.1 %  32  22.86 
% 
15  6 % 
Dimorphic 
anemia 
-  -  25  17.86 
% 
47  18.8 
% 
Total  74  100 %  140  100 %  250  100 
% 
Mean  RBC  count  was  3.66  million/mm
3  with  a  standard 
deviation of 0.84. Tripathi et al reported a mean RBC count 
of 3.09 and  a standard deviation of 0.36 among 55 AIDS 
patients.
 Mean of MCV (mean corpuscular volume) in the 
present study was 87.3. Tripathi et al reported a mean of 
81.81 (N=55 patients).
7 In the present study the majority of 
cases 178 (71.2%) had MCV within normal range (80-99 fl) 
indicating normocytic nature of RBCs. 
MCH was 28.4. A similar observation was made by Tripathi 
et al with a mean of 27.59.
7 MCHC ranged from 25.9gm/dl 
to  36.2gm/dl  with  the  mean  being  32.5  and  standard 
deviation of 1.74. One hundred and sixty nine (67.6%) cases 
had  MCHC  between  31.5  to  34.5gm/dl  indicating 
normochromasia in the majority of patients. 
Mean haematocrit in the present study was 31.33. Tripathi 
et al reported a mean haematocrit of 27.36.
7 Mean RDW-CV 
was 15.7 indicating mild anisocytosis. A similar observation 
was made by Schneider et al.
8 
In the present study anaemia was seen in 210 (84%) cases. 
A similar observation was made by Kaloutsi et al in 34/40 
(85%)  cases.
5  Karcher  et  al  reported  anaemia  in  175/197 
(89%)  patients,  and  Tripathi  et  al  in  61/74  (82.4%) 
patients.
7,9  However Sitalakshmi et al reported anaemia in 
27/42 (64.2%) cases which is much lower compared to the 
present study.
10 Table 2 shows a comparison of number of 
anaemia cases in the present study with other studies. The 
most  common  type  of  anaemia  was  normocytic 
normochromic  type  in  101  (40.4%)  cases.  A  similar 
observation  was  made  by  Khandekar  et  al  in 
68/140(48.57%)  cases.
11  A  comparison  of  morphological 
patterns of blood picture in the present study with other 
studies is given in Table 3.  
Mean total leucocyte count was 5827.8 cells/mm3. Kaloutsi 
et al reported a mean of 5200 cells/mm3.
5 The majority of 
176  (70.4%)  cases  had  a  normal  total  leucocyte  count.  A 
similar  observation  was  made  by  Patwardhan  et  al  in 
378/500 (75.6%) cases.
12 Leucopenia was seen in 52 (20.8%) 
cases.  In  the  present  study  eosinophilia  was  seen  in  54 
(21.6%)  cases.  Khandekar  et  al  observed  eosinophilia  in 
16/140 (11.43%) cases.
11 
Lymphopenia  (absolute  lymphocyte  count  less  than  1500 
cells/mm
3)  was  seen  in  163  (65.2%)  cases.  Treacy  et  al 
reported  lymphopenia  in  14/20  (70%)  cases.
6  However 
Tripathi  et  al  observed  a  lower  number  of  lymphopenia 
cases in 19/74 (25.6%) cases.
7 
In  the  present  study  thrombocytopenia  was  seen  in  45 
(18%) cases. This has been reported by Patwardhan et al in 
65/500 (13%) cases and Costello C et al in 121/925 (13%) 
cases.
12,13  However  Karcher  et  al  reported 
thrombocytopenia  in  88/196  (45%)  cases,  much  higher 
compared to the present study.
 9 Mean ESR in the present 
study was 61.2 mm at the end of the first hour indicating 
high ESR in HIV patients. 
CD4  lymphocyte  count  is  essential  for  assessment  of 
immune status in HIV-infected persons as the pathogenesis 
of AIDS is largely attributed to a decrease in absolute CD4  Australasian Medical Journal [AMJ 2012, 5, 3, 157-162] 
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cell counts. CD4 cell counts are the criterion for categorising 
HIV-related clinical conditions by CDC classification system 
for  HIV  infection.
3  Patients  in  the  present  study  were 
divided into three groups based on CD4 lymphocyte count.
 
Haematological parameters were compared in these three 
groups  (Table  1).  The  number  of  cases  with  anaemia, 
leucopenia, and lymphopenia increased with reducing CD4 
cell  counts.  Mean  total  leucocyte  count,  mean  absolute 
lymphocyte count was lower with reducing CD4 cell counts, 
and  mean  ESR  increased  with  reducing  CD4  cell  counts. 
These parameters showed significant difference (indicated 
by  p  value  less  than  0.05)  between  three  groups  with 
differing CD4 cell counts. This indicates a higher occurrence 
of anaemia, lymphopenia and leucopenia with progression 
of disease. Though there was a difference in mean platelet 
count between these three groups, it was not statistically 
significant,  indicating  occurrence  of  thrombocytopenia 
independent of disease progression.   
Anaemia  in  HIV-infected  patients  is  likely  to  be 
multifactorial. Inflammatory cytokines play a central role in 
the  pathogenesis  of  anemia.  TNF,  IL-1  and  interferon 
gamma  have  all  been  shown  to  inhibit  erythropoiesis  in 
vitro.
14  TNF  levels  have  been  shown  to  be  consistently 
elevated  in  HIV  infection  and  correlate  with  viral  load.
15 
Dyserythropoiesis and opportunistic infections also result in 
certain  haematologic  abnormalities.
16  Severe  anaemia  has 
been  reported  to  be  present  in  76%  of  patients  with 
disseminated  mycobacterium  avium  complex  (MAC) 
disease.
15  Chronic pure red cell aplasia has been reported 
to  occur  in  HIV-infected  patients  with  parvovirus  B19 
infection.
17  Anaemia  in  HIV-infected  patients  is  known  to 
occur as an adverse effect of drug therapy for HIV infection 
or  its  complications.  Myelosuppression  mainly  macrocytic 
anaemia is the dose limiting toxicity of zidovudine. Other 
drugs  that  are  associated  with  anaemia  in  AIDS  patients 
include primaquine, dapsone and ganciclovir.
 15 
Leucopenia  generally  correlates  with  the  severity  of  a 
clinical  syndrome  like  anaemia.
18  Reduction  in  absolute 
number  of  CD4  T  cells  occurs  as  one  of  the  earliest 
immunologic abnormalities of HIV infection and is the most 
important  prognostic  indicator  for  risk  of  developing 
opportunistic infections.
 14 
The  mechanism  of  thrombocytopenia  in  HIV  infection 
appears  to  involve  increased  platelet  destruction  and 
ineffective platelet production. Most reports indicate that 
there is significant platelet sequestration and destruction in 
the  spleen  in  HIV-associated  thrombocytopenia.  Platelet 
destruction is predominant early in the course of disease, 
whereas decreased platelet production is the predominant 
factor later in the course of the disease. Antibodies directed 
against  platelet  glycoprotein  IIIa,  similar  to  those  seen  in 
classic  ITP  are  seen.
14  Megakaryocytes  express  CD4  and 
CXCR4 and are susceptible to infection by HIV. Studies of 
megakaryocytes  from  HIV-infected  patients  have  shown 
viral  RNA  and  proteins  suggesting  that  these  cells  are 
infected in vivo.
19 Other causes include marrow infiltration 
by  opportunistic  infection  or  lymphoma,  TTP,  and 
myelosuppressive effects of drug therapy.
 15 
Drugs  used  to  treat  HIV  infection  and  other  infections 
associated with HIV frequently cause haematologic toxicity. 
Several  in  vitro  studies  have  shown  that  zidovudine  and 
dideoxycytidine inhibit erythroid colony forming units (CFU-
E)  and  granulocyte  macrophage  colony  forming  units. 
Zidovudine  is  phosphorylated  to  an  active  triphosphate 
moiety  by  mammalian  enzymes  and  the  resulting 
metabolite  may  be  responsible  for  inducing  toxicity. 
Ganciclovir  causes  leucopenia.  Pyrimethamine  and 
sulfadiazine used in the treatment of toxoplasmosis causes 
leucopenia  and  thrombocytopenia.  Chemotherapeutic 
agents  used  in  the  treatment  of  malignancies  result  in 
myelosuppression  which  is  often  dose  limiting.  Alpha 
interferon  used  in  the  treatment  of  Kaposi  sarcoma  is 
frequently associated with haematologic toxicity.
20 
Conclusion 
Haematologic  manifestations  are  common  in  HIV-infected 
patients.  Anaemia is the most common manifestation and 
the most frequent form is normocytic and normochromic 
type.  Significant  numbers  of  patients  also  show 
lymphopenia and thrombocytopenia. Incidence of anaemia 
and  leucopenia  correlates  with  disease  progression. 
Thrombocytopenia  occurs  independent  of  disease 
progression.  The  present  study  also  showed  significant 
correlation  of  absolute  lymphocyte  count  with  CD4  cell 
counts. Thus absolute lymphocyte count can be used as a 
predictor of CD4 counts and can be used to assess the stage 
of the disease in centres where CD4 count evaluation is not 
available.  At  the  same  time  patients  with  HIV  infection 
should  be  investigated  and  treated  for  haematological 
abnormalities to reduce the morbidity of the patient.  
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